2012
DOI: 10.3923/ajava.2012.1245.1254
|View full text |Cite
|
Sign up to set email alerts
|

Advances in Studies on Vaccines of Foot-and-mouth Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2013
2013
2021
2021

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 39 publications
0
2
0
Order By: Relevance
“…Immunoinformatics approach uses computational algorithms to predict potential vaccine candidates or T-cell epitopes. The advantage of a peptide- or epitope-based vaccine is the ability to deliver high doses of the potential immunogen and at a low cost (Von Hoff et al 2005; Tang et al 2012b). Viral protein which could act as a vaccine candidate must be surface-exposed, antigenic and responsible for pathogenicity (Cerdino-Tarraga et al 2003; Verma et al 2011).…”
Section: Introductionmentioning
confidence: 99%
“…Immunoinformatics approach uses computational algorithms to predict potential vaccine candidates or T-cell epitopes. The advantage of a peptide- or epitope-based vaccine is the ability to deliver high doses of the potential immunogen and at a low cost (Von Hoff et al 2005; Tang et al 2012b). Viral protein which could act as a vaccine candidate must be surface-exposed, antigenic and responsible for pathogenicity (Cerdino-Tarraga et al 2003; Verma et al 2011).…”
Section: Introductionmentioning
confidence: 99%
“…Now a days, scientists have realized many disadvantages of this vaccine and it is very difficult to maintain consistent potency of vaccine and much research continues for developing alternative vaccine strategies that do not require infectious virus viz. proteins/peptides and various recombinant DNA-based strategies, including vectored, virus-like particle (Mohana et al, 2012;Scotti and Rybicki, 2013), gene replacement , empty viral capsids having desired immunogens but lacking infectious nucleic acid and DNA vaccines, synthetic peptide vaccine, epitope based vaccines, chimeric virus vaccines using reverse genetics technology and so on (Seago et al, 2012;Tang et al, 2012b;Zheng et al, 2013). Live attenuated vaccines have also been attempted by serial passaging in non-permissive cell culture or animals (classically), but with limited success.…”
Section: Inactivated Fmd Vaccinesmentioning
confidence: 99%